SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-002102
Filing Date
2018-01-16
Accepted
2018-01-12 17:33:02
Documents
3
Period of Report
2018-01-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-3135_28k.htm 8-K 27730
2 EX-99.1 a18-3135_2ex99d1.htm EX-99.1 6269
3 GRAPHIC g31352mmi001.gif GRAPHIC 6580
  Complete submission text file 0001104659-18-002102.txt   44518
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 18526731
SIC: 2834 Pharmaceutical Preparations